Wednesday, June 09, 2021 10:01:14 PM
This rally cycle has been
a pretty strong bullish development.
and my main reason for saying that is because it came off the Lower Low at 10 dollars, that was a breakdown from the 11 dollar previous Bottom. That new lower low, on a technical basis, 'should' have/could have turned the bias bearish at least for a while, but what we saw, was a pretty strong rally climb, from 10 to 12, that pulled back and held 11, like it 'should' in a bullish momentum, and then 11 became a steady climber that didnt stop until 16, while I was expecting to see the bearish selling start coming in at 13.00-13.50 area, and maybe peak at 14. so what we have now seen is a bullish looking surge to 16 and now some resistance toppy curve around 15.50 area to watch out for. But my main take away, is that there was not the strong resistance at 13.00-14.00 area.That surprised me. There was a big pullback sell down from 16 to 14.10 , but then we just saw a good recovery back to retest 15.60 area, so the bias that I think should have been bearish when it fell to 10, got turned right around and became more bullish looking.Still having said that,The Range Pattern, the zone from 11 to 16,and 10 to 16 has to still be considered in play, and for that to change we need to see a breakout beyond 16.
If we see a finished wave at 16 now, the basic pullback area on the math chart is the 13.50-13.00-12.75 area to watch for. IF the bullish momentum would take over stronger we could see te support step at 14 area holding.
In the climb from 10 dollars we saw support hold at 11.07/12.40/13.10/14.10
AVXL 5 minute candles
a pretty strong bullish development.
and my main reason for saying that is because it came off the Lower Low at 10 dollars, that was a breakdown from the 11 dollar previous Bottom. That new lower low, on a technical basis, 'should' have/could have turned the bias bearish at least for a while, but what we saw, was a pretty strong rally climb, from 10 to 12, that pulled back and held 11, like it 'should' in a bullish momentum, and then 11 became a steady climber that didnt stop until 16, while I was expecting to see the bearish selling start coming in at 13.00-13.50 area, and maybe peak at 14. so what we have now seen is a bullish looking surge to 16 and now some resistance toppy curve around 15.50 area to watch out for. But my main take away, is that there was not the strong resistance at 13.00-14.00 area.That surprised me. There was a big pullback sell down from 16 to 14.10 , but then we just saw a good recovery back to retest 15.60 area, so the bias that I think should have been bearish when it fell to 10, got turned right around and became more bullish looking.Still having said that,The Range Pattern, the zone from 11 to 16,and 10 to 16 has to still be considered in play, and for that to change we need to see a breakout beyond 16.
If we see a finished wave at 16 now, the basic pullback area on the math chart is the 13.50-13.00-12.75 area to watch for. IF the bullish momentum would take over stronger we could see te support step at 14 area holding.
In the climb from 10 dollars we saw support hold at 11.07/12.40/13.10/14.10
AVXL 5 minute candles
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
